Expertise in
14
conditions

Dr. Steven R. Bonin

Radiology | Radiation Oncology
St Lukes Hospital Of Duluth
1015 E 1st St, 
Duluth, MN 
 (1099.0 mi)
Accepting New Patients
Expertise in
14
conditions
St Lukes Hospital Of Duluth
1015 E 1st St, 
Duluth, MN 
 (1099.0 mi)
OverviewInsuranceLocationsClinical Research

Overview

Steven Bonin is a Radiologist and a Radiation Oncologist in Duluth, Minnesota. Dr. Bonin is highly rated in 14 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Laryngeal Cancer. Dr. Bonin is currently accepting new patients.

His clinical research consists of participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Radiology
Radiation Oncology
Licenses
Diagnostic Radiology in MN
Hospital Affiliations
Lake View Memorial Hospital
St Lukes Hospital
Languages Spoken
English
Gender
Male

Insurance

Please contact the provider to confirm they accept your insurance or if you don't see your insurance listed.

Accepted insurance plans

  •  Medica
  •  Security Health
  •  Humana

Locations

ST LUKES HOSPITAL OF DULUTH
1015 E 1st St, Duluth, MN 55805

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

10 Clinical Trials

Phase II Randomized Trial of Immunotherapy Versus Immunotherapy and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (IMMORTAL)
Phase II Randomized Trial of Immunotherapy Versus Immunotherapy and Radiation Therapy for Platinum Ineligible/Refractory Metastatic Urothelial Cancer (IMMORTAL)
Enrollment Status: Terminated
Publish Date: January 29, 2025
Intervention Type: Procedure, Other, Biological, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 2
A Randomized Phase III Trial of Hypofractionated Post-prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-prostatectomy Radiation Therapy (COPORT)
A Randomized Phase III Trial of Hypofractionated Post-prostatectomy Radiation Therapy (HYPORT) Versus Conventional Post-prostatectomy Radiation Therapy (COPORT)
Enrollment Status: Active_not_recruiting
Publish Date: January 23, 2025
Intervention Type: Radiation, Drug
Study Phase: Phase 3
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Phase II-III Trial of Adjuvant Radiotherapy and Androgen Deprivation Following Radical Prostatectomy With or Without Adjuvant Docetaxel
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2025
Intervention Type: Drug, Other, Radiation
Study Drugs: Bicalutamide, Docetaxel, Flutamide, Goserelin acetate, Leuprolide acetate, Nilutamide
Study Phase: Phase 2/Phase 3
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Randomized Phase II Trial of Hypofractionated Dose-Escalated Photon IMRT or Proton Beam Therapy Versus Conventional Photon Irradiation With Concomitant and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma
Enrollment Status: Active_not_recruiting
Publish Date: January 22, 2025
Intervention Type: Other, Drug, Radiation
Study Drug: Temozolomide
Study Phase: Phase 2
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
A Phase IIR/III Trial of Standard of Care Therapy With or Without Stereotactic Body Radiotherapy (SBRT) and/or Surgical Ablation for Newly Oligometastatic Breast Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 16, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 2/Phase 3
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy
Enrollment Status: Active_not_recruiting
Publish Date: January 13, 2025
Intervention Type: Radiation, Procedure
Study Phase: Phase 3
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial
Enrollment Status: Active_not_recruiting
Publish Date: September 19, 2024
Intervention Type: Radiation
Study Phase: Phase 3
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Randomized Phase II/III Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 17, 2024
Intervention Type: Radiation
Study Phase: Phase 2/Phase 3
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
A Phase III Study of Postoperative Radiation Therapy (IMRT) +/- Cetuximab for Locally-Advanced Resected Head and Neck Cancer
Enrollment Status: Active_not_recruiting
Publish Date: May 28, 2024
Intervention Type: Biological, Radiation
Study Drug: Cetuximab
Study Phase: Phase 3
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Maintenance Systemic Therapy Versus Local Consolidative Therapy (LCT) Plus Maintenance Systemic Therapy for Limited Metastatic Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II/III Trial
Enrollment Status: Active_not_recruiting
Publish Date: April 05, 2024
Intervention Type: Radiation, Drug
Study Drugs: Docetaxel, Gemcitabine, Pemetrexed Disodium, Erlotinib Hydrochloride, Pembrolizumab
Study Phase: Phase 2
View 9 Less Clinical Trials
Similar Doctors
Expertise in
18
conditions
Dr. Nils D. Arvold
Radiation Oncology
Expertise in
18
conditions
Dr. Nils D. Arvold
Radiation Oncology

St Lukes Hospital Of Duluth

1001 E Superior St, Suite 201, 
Duluth, MN 
 (0.5 mi)
218-249-7980
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Nils Arvold is a Radiation Oncologist in Duluth, Minnesota. Dr. Arvold is highly rated in 18 conditions, according to our data. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Familial Prostate Cancer, and Posterior Fossa Tumor. Dr. Arvold is currently accepting new patients.

Expertise in
20
conditions
Dr. Larry D. Grubb
Radiation Oncology
Expertise in
20
conditions
Dr. Larry D. Grubb
Radiation Oncology

Range Regional Health Services

750 E 34th St, 
Hibbing, MN 
 (57.7 mi)
218-262-4881
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Larry Grubb is a Radiation Oncologist in Hibbing, Minnesota. Dr. Grubb is highly rated in 20 conditions, according to our data. His top areas of expertise are Pleuropulmonary Blastoma, Lung Cancer, Familial Prostate Cancer, and Posterior Fossa Tumor. Dr. Grubb is currently accepting new patients.

Expertise in
63
conditions
Dr. Michael E. Ryan
Radiology
Expertise in
63
conditions
Dr. Michael E. Ryan
Radiology
400 E 3rd St, 
Duluth, MN 
 (0.6 mi)
218-786-8364
Languages Spoken:
English

Michael Ryan is a Radiologist in Duluth, Minnesota. Dr. Ryan is highly rated in 63 conditions, according to our data. His top areas of expertise are Ureterocele, Lung Nodules, Breast Lump, and Scrotal Swelling.

Areas of Expertise

When evaluating expertise, MediFind pulls from factors such as the number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

To learn more about how MediFind determines the expertise levels, check out our expert tiers page.

Search for your specific condition
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile